CIK 0001395064 · Large accelerated filer
TAKEDA PHARMACEUTICAL CO LTD
Sign in to watch- Ticker
- TKPHF
- Exchange
- NYSE, OTC
- Industry
- Pharmaceutical Preparations
- Entity type
- other
- Phone
- 81332782111
- Business address
- 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, Japan, 103-8668
Securities
- TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) NYSE
- TKPHF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,523,173
- in 6 filings, $2.5M under 10b5-1 plans
Net −$5,523,173. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Plump Andrew Stewart −$2.5M President, R&D sold 48% of stake
- Platford Giles Richard −$1.2M President, IBU sold 17% of stake
- Bitetti Teresa Marie −$974K President, OBU sold 18% of stake
- Duprey Lauren Rusckowski −$640K Chief Transformation Officer sold 15% of stake
- Greenway Nicola Deidre Petal −$235K Chief Human Resources Officer sold 24% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-27 | Kim Julie So-Young CEO - Elect | Grant or award | +105,416 | 430,145 | ||
| 2026-04-27 | Platford Giles Richard President, IBU | Grant or award | +72,124 | 297,363 | ||
| 2026-04-27 | Pignagnoli Agosti Marcello Head, Strat. & Port. Dev. | Grant or award | +27,740 | 172,348 |
Page 5 of 5 · 83 trades